BIOCHEMICAL SOCIETY TRANSACTIONS kallikrein activities (Fig. 2a) . a,-Proteinase inhibitor concentrations (0.28, 4.44 and 4.44mg/ml) were chosen that produced inhibition (to 37,42 and 32% of control rates respectively) of thrombin-(substrate S-2238), 7s-NGF-(substrate s-2302) and kallikrein-(substrate s-2302) catalysed amidolysis respectively. Heparin alleviated a,-proteinase inhibition of thrombin, but did not affect inhibition of 7S-N G F or kallikrein (Fig. 2b) . Similar effects of a,-proteinase inhibitor and of heparin were observed on 5s-NGF-catalysed amidolysis of substrates S-2288, S-2251 and S-2238 and on kallikrein-catalysed amidolysis of substrate S-2266.
Heparins modulate proteinases in several ways, many involving interactions with proteinase inhibitors. Variations in structures of pericellular heparans may affect the ability of these molecules to influence cell-proliferation-associated surface proteinase activities (including those associated with peptide growth factors) (Long & Williamson, 1983) . 7 s -N G F activity was compared with that of a glandular kallikrein because of sequence similarities between kallikrein and 7s-NGF y-subunit (Fiedler & Fritz, 1981 ; Lazure et al., 1981) , and with that of thrombin because of the known influence of glycosaminoglycans on thrombin activity (summarized in Long & Williamson, 1983) . Results reported here suggest that heparin (or heparan) modulation of 7s-NGF activity through the action of antithrombin I11 or a,-proteinase inhibitor is unlikely. A nerve growth factor preparation is able to substitute for component CT of the classical complement pathway, presumably through the action of the y-subunit; tkis action is prevented by the plasma antkroteinase Cls-inhibitor (Boyle & Young, 1982 A rapid method was sought for the purification of bacterial methionyl-(human somatotropin) (Goeddel et al., 1979) to minimize proteolysis of the hormone during purification. Immuno-affinity chromatography was investigated, since it was likely to provide a highly selective method allowing purification in a single step. Antibody raised against human somatotropin purified from pituitaries, although not absolutely specific for somatotropin owing to the small amounts of contaminating glycoprotein hormones in all such preparations, should recognize only one protein in an extract of the Escherichia coli strain carrying a derivative of the plasmid pHGH 107 developed by Genentech for methionyl-(human somatotropin) production. Antiserum to human somatotropin was raised in sheep by using a purified pituitary preparation (Jones et al., 1979) as antigen. On days 1 and 28 the animals were injected intramuscularly in each limb with 1 ml of a 0.25mg/ml solution of antigen in Freund's complete adjuvant and at day 56 with a half dose. At day 66 antibody was detectable in the sera, and 200ml of blood were taken per bleed 1 week after a boost with a half dose. The immunoglobulin fraction was prepared by ion-exchange chromatograph on DEAE-cellulose equilibrated against 20mM-sodium phosphate buffer, pH8.0, and subsequent gel filtration through Sephadex G -150 equilibrated against 0.2 M-sodium bicarbonate buffer, pH 8.6, containing 0 . 5~-N a C I .
Anti-(human somatotropin) immunoglobulin G-containing fractions were identified by immunodiffusion.
Immobilization of the immunoglobulin G on CNBr-activated Sepharose 4B was performed in the gel-filtration buffer. The reaction was carried out at room temperature for 6 h with lOmg of immunoglobulin G/ml of Sepharose and resulted in greater than 90% coupling. The gel was washed with several cycles of 0.1 M-borate, pH 8.0, and 0.1 Macetate buffer, pH 4.0, both containing 0.5M-NaCI, before use.
The bacterial culture was killed by treatment at pH 12 for IOmin (Sherwoodetal., 1982) , and then the pH was lowered to 8.5 and the cell debris was removed by centrifugation at 35000g for IOmin. The supernatant was dialysed overnight at 4°C against 200~01. of SOmM-Tris/HCl buffer, pH8.5, containing 0.1 M-NaCI and 0.5% (v/v) Tween 80 (Eveleigh & Levy, 1977) , while the gel was equilibrated with the second buffer. Under these conditions the gel had a capacity for methionyl-(human somatotropin) of 0.5 mg/ml. Elution of the hormone was not achieved by 0.1 M-Tris, pH 10.5, containing O.SM-NaC1, O.SM-NaC1 adjusted to pH 12 with conc. ammonia (sp.gr. 0.880) or 2 . 5~-K 1 in 0.1 M-Tris/HCI buffer, pH9.5. After washing with water, elution was not achieved with 0.1 M-aCetiC acid, but addition of either 6~-guanidinium chloride (AristaR grade; BDH Chemicals) or 8M-urea (AnalaR grade; BDH Chemicals) to the acetic acid eluted the hormone as a sharp peak. Elution of the conjugate with 8 M-UTea in 0.1 M-sodium phosphate buffer, pH 7.0, resulted in slight leakage of the hormone from the gel.
The result of a purification is shown in Fig. 1 , which illustrates the high degree of purity achieved by the single step. Besides the monomer band, only a small amount of 20kDa variant is seen, and no dimeric material nor the 24kDa variant were observed (Lewis et al., 1976) . These variants, however, do appear if the extract is kept for several days before purification, indicating that E. coli contains a proteinase capable of nicking the hormone, as occurs in the pituitary. After the removal of the urea or guanidinium chloride by dialysis the hormone cross-reacted with its antibody and retained its characteristic u.v.-absorption spectrum. Human somatotropin has been shown previously to retain its biological activity under acid conditions or after treatment with urea (Bewley & Li, 1975 Subsequent experiments with 1251-labelled (Fraker & Speck, 1978) immobilized immunoglobulin G revealed leakage of small amounts, in the 1-1Opg range, of immunoglobulin G or immunoglobulin G fragments into the hormone-containing fractions; this.represented less than 3% of the total proteins. The bulk of the radioactivity was associated with high-molecular-mass material and may readily be removed from the hormone by gel filtration on Sephadex
The method is successful for methionyl-(human somatotropin) largely because of the remarkable stability of the molecule under denaturing conditions. It is, however, unlikely to be useful commercially, owing to the low capacity of the immunoadsorbent for the hormone. On a small scale it is successful in rapidly producing methionyl-(human somatotropin) of high quality with little proteolytic damage suitable for use as in-house standards for radio-immune or rocket assays. Yields of 90% recovery on the step have been regularly obtained.
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Abbreviation: cDNA, complementary DNA.
VOl. 12 E Total mRNA was prepared from sheep pituitaries (Austin & Wallis, 1979) and translated in a reticulocyte-lysate cell-free system in the presence of [35S]methionine. Labelled preprolactin and presomatotropin were identified after immunoprecipitation and sodium dodecyl sulphate/polyacrylamide gel electrophoresis : they represented 30% and 6% respectively of the translation products (based on [35S]methionine incorporation). Miller et al. (1980) found a similar, but less marked, preponderance of incorporation into preprolactin with mRNA obtained from bovine pituitary glands.
cDNA was prepared using total pituitary mRNA as template and was cloned into the HindIII site of plasmid PAT 153 (Twigg & Sherratt, 1980) by using HindIII linkers. Recombinant plasmids were used to transform Escherichia coli strain MRC 8, and clones containing plasmids with inserts encoding presomatotropin cDNA were identified by hybrid-arrest of translation. One such plasmid (pOGH 4), containing a fairly large insert, was chosen for further characterization.
The nucleotide sequence of the insert in pOGH 4, encoding cDNA corresponding to mRNA for somatotropin from the beginning of the signal peptide, was determined by se-
